Levy Ari Insider Profile

4 Followers
Levy Ari, Former at Vaxil Bio, holds 476.10K shares in Vaxil Bio (Ticker: TSE:VXL). Most recently, Levy Ari Bought C$238,000 shares of Vaxil Bio on May 08, 2015 for an estimated value of 11.90K.
tipranks
Levy Ari

Levy Ari
Vaxil Bio (VXL)
Former

Not Ranked
Levy Ari has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

C$5K
100.00%
A breakdown of Levy Ari's holdings

Insider Roles

Vaxil Bio
(VXL)
Former
Roles that Levy Ari holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Levy Ari

Levy Ari's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Vaxil Bio
May 08, 2015
Former
Informative Buy
11.90K
C$4.76K
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
May 08, 2015
Informative Buy
C$11.90K
-
C$0.05
List of latest transactions for each holding click on a transaction to see Levy Ari's performance on stock

Levy Ari insider profile FAQ

What is the percentage of profitable transactions made by Levy Ari?
The percentage of profitable transactions made by Levy Ari is ―.
    What is the average return per transaction made by Levy Ari?
    The average return per transaction made by Levy Ari is ―.
      What stocks does Levy Ari hold?
      Levy Ari holds: TSE:VXL stocks.
        What was Levy Ari’s latest transaction?
        Levy Ari latest transaction was an Informative Buy of C$11.90K.
          What was Levy Ari's most profitable transaction?
          Levy Ari’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Levy Ari's role in Vaxil Bio?
            Levy Ari's role in Vaxil Bio is Former.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.